<DOC>
	<DOCNO>NCT00947609</DOCNO>
	<brief_summary>The study prospective study improve diagnosis management latent TB HIV-infected HIV uninfected child Thailand . The objective assess sensitivity specificity IGRAs ( T-Spot®.TB , T-cell-based assay , QuantiFERON®-TB Gold In-tube , whole blood assay ) , TST , refine symptom-based questionnaire diagnose latent TB 166 HIV-infected HIV uninfected child Thailand , evaluate influence age , nutritional immune status child 's response IGRAs . These child screen TB detail TB contact history , symptom-based questionnaire , physical examination , TST , chest radiograph ( abdominal ultrasound abdominal symptom ) , IGRAs , clinical specimen acid fast bacillus stain culture . A diagnostic algorithm generate use combination test modality high sensitivity specificity result .</brief_summary>
	<brief_title>Improving Latent Tuberculosis ( TB ) Diagnosis Thai Children</brief_title>
	<detailed_description>Study Objectives - To compare utility IGRAs , T-Spot®.TB QuantiFERON®-TB Gold In-Tube , TST screen latent TB HIV-infected child - To compare different screen modality HIV-infected child HIV uninfected child - To assess influence age , nutritional immune status , prior BCG TST status child 's response IGRAs - To assess prognostic value IGRAs vs. TST predict development active TB child 9 month Research question : Primary : What sensitivity specificity IGRAs TST screen latent TB HIV-infected HIV uninfected child Thailand ? Secondary : How age , nutritional immune status , prior BCG PPD status influence child 's response IGRAs ? What prognostic value IGRAs vs. TST predict development active TB child 9 month ? This prospective cohort study conduct two site Bangkok , Thailand : HIV Netherlands Australia Thailand ( HIV-NAT ) Clinic/Chulalongkorn Hospital Queen Sirikit National Institute Child Health .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<criteria>1 . Have close contact person &gt; 15 year age active pulmonary ( ± extrapulmonary ) , sputum AFB positive TB ( household member nonhousehold member contact &gt; 120 hours/month ) past year 2 . Are age 2 month 16 year 3 . Parents caregiver provide inform consent participate 4 . Provide child assent child age ≥ 7 year 1 . Child and/or parent/caregiver refuse study participation 2 . Are currently receive antituberculosis medication TB disease 3 . Have recently diagnose active TB within past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Latent tuberculosis</keyword>
	<keyword>HIV</keyword>
	<keyword>Children</keyword>
	<keyword>Interferon gamma release assay</keyword>
	<keyword>Thailand</keyword>
	<keyword>QuantiFERON TB Gold In-tube</keyword>
	<keyword>T-Spot.TB</keyword>
</DOC>